CapBuster

A new medical device to safely and reliably penetrate chronic total occlusions

General Information
Company Name
CapBuster
Founded Year
2018
Location (Offices)
Ireland +1
Founders / Decision Makers
Number of Employees
2
Industries
Design, Medical Devices
Funding Stage
Pre Seed
Social Media

CapBuster - Company Profile

Capbuster is an Irish-based startup founded in 2018, specializing in medical devices. The company's innovative product is a guidewire & balloon catheter combination device designed to penetrate chronic total occlusions in a safe and reliable manner. The device incorporates engineering intelligence previously unused in angioplasty and features a unique patented technology.

The CapBuster device sets itself apart with a male screw-thread on the guidewire and a female screw-thread in the catheter, providing a mechanical advantage for gradual, sustained pressure during the procedure. This enables clinicians to penetrate the most resistant occlusions while exercising absolute control, leading to reduced procedure time, improved safety, and efficacy. Moreover, it allows non-specialist CTO clinicians to participate in saving lives and limbs.

In June 2020, CapBuster secured a €40.00K Pre Seed Round investment, with the primary funding coming from EIT Health. The recent investment will likely facilitate the advancement and commercialization of their groundbreaking medical device, positioning them favorably within the medical technology industry for potentially revolutionary impact.

Taxonomy: medical device, safety, cath lab, angioplasty, guidewire technology, chronic total occlusions, screw-thread technology, balloon catheter, interventional cardiology, innovation, physician tool, cardiovascular medicine

Funding Rounds & Investors of CapBuster (1)

View All
Funding Stage Amount No. Investors Investors Date
Pre Seed Round €40.00K 1 EIT Health 02 Jun 2020

Latest News of CapBuster

View All

No recent news or press coverage available for CapBuster.

Similar Companies to CapBuster

View All

No funding or investment information available for CapBuster at this time.